1. Show article details.

    BRIEF-Stryker Releases Emergency Relief Bed, A Limited-Release Medical Bed To Support Critical Needs During Pandemic

    Reuters – 8:40 AM ET 04/03/2020

    Stryker Corp (SYK): * STRYKER RELEASES EMERGENCY RELIEF BED™, A LIMITED-RELEASE MEDICAL BED TO SUPPORT CRITICAL NEEDS DURING PANDEMIC Source text for Eikon: Further company coverage:

  2. Show article details.

    Healthcare stocks show their defensive allure in ailing market

    Reuters – 10:28 AM ET 04/02/2020

    The coronavirus pandemic is throwing a spotlight on stocks in the U.S. healthcare sector, home to the companies that could develop treatments, vaccines and improved diagnostics needed to tackle the greatest public health crisis in a century. Healthcare has held up better than most S&P 500 sectors.

  3. Show article details.

    Healthcare stocks show their defensive allure in ailing market

    Reuters – 10:20 AM ET 04/02/2020

    The coronavirus pandemic is throwing a spotlight on stocks in the U.S. healthcare sector, home to the companies that could develop treatments, vaccines and improved diagnostics needed to tackle the greatest public health crisis in a century. Healthcare has held up better than most S&P 500 sectors.

  4. Show article details.

    Mexico scrambles to meet desperate U.S., European ventilator demand

    Reuters – 3:53 PM ET 04/01/2020

    Mexico's medical device industry is scrambling to meet an eleven-fold jump in demand for ventilators as patients with respiratory conditions linked to the coronavirus pandemic overwhelm hospitals in the United States and Europe.

  5. Show article details.

    BRIEF-Stryker Corp Withdrawing Its Q1, FY Organic Sales Growth And EPS Guidance

    Reuters – 5:50 PM ET 03/31/2020

    Stryker Corp (SYK): * Stryker Corp (SYK) - WITHDRAWING ITS FIRST QUARTER AND FULL YEAR 2020 ORGANIC SALES GROWTH AND EARNINGS PER SHARE GUIDANCE Source text: https://bit.ly/3bGLJ4s Further company coverage:

  6. Stryker stock price target cut to $162 from $247 at SVB Leerink

    MarketWatch – 8:54 AM ET 03/25/2020
  7. Show article details.

    Stryker announces Annual Meeting of Shareholders

    GlobeNewswire – 10:00 AM ET 03/24/2020

    Stryker announced its 2020 Annual Meeting of Shareholders is scheduled as follows: May 5, 2020 – 2:00 p.m. Eastern Time. Due to concerns regarding the coronavirus outbreak and to assist in protecting the health and well-being of our shareholders and employees, this year’s Annual Meeting of Shareholders of Stryker Corporation (SYK) will be held virtually via the internet.

  8. Stryker stock price target cut to $145 from $250 at Stifel Nicolaus

    MarketWatch – 7:49 AM ET 03/24/2020
  9. Show article details.

    Stryker announces new Investor Relations leader

    GlobeNewswire – 8:00 AM ET 03/02/2020

    Stryker announced today that Preston Wells will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective June 1, 2020. After a very successful thirteen-year period, Katherine Owen, Vice President, Strategy and Investor Relations has decided to retire to spend more time with her family.

  10. Show article details.

    BRIEF-Stryker Extends Cash Tender Offer For All Outstanding Shares Of Wright Medical

    Reuters – 8:01 AM ET 02/26/2020

    Stryker Corp (SYK): * STRYKER EXTENDS CASH TENDER OFFER FOR ALL OUTSTANDING SHARES OF WRIGHT MEDICAL. * Stryker Corp (SYK) - TENDER OFFER IS NOW SCHEDULED TO EXPIRE ON APRIL 30 Source text for Eikon: Further company coverage:

  11. Show article details.

    Stryker extends cash tender offer for all outstanding shares of Wright Medical

    GlobeNewswire – 8:00 AM ET 02/26/2020

    Stryker announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V.. The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical.

  12. Show article details.

    Stryker to participate in Cowen 40th Annual Health Care Conference

    GlobeNewswire – 2:00 PM ET 02/25/2020

    Stryker ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts. Katherine Owen, Vice President, Strategy & Investor Relations, will represent the Company in a presentation scheduled for 10:40 a.m. Eastern Time.

  13. Show article details.

    Stryker announces nomination of new Director, Lisa Skeete Tatum

    GlobeNewswire – 8:08 AM ET 02/25/2020

    Stryker announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020. Ms. Skeete Tatum is the Founder and Chief Executive Officer of Landit, Inc., a technology platform created to increase the success and engagement of women and diverse groups in the workplace.

  14. Show article details.

    Stryker named to the 100 Best Companies to Work For list for 10th consecutive year

    GlobeNewswire – 8:15 AM ET 02/18/2020

    Kalamazoo, Michigan – February 18, 2020 – Stryker, one of the world’s leading medical technology companies, announced today it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States for a 10th consecutive year.

  15. Show article details.

    BRIEF-Stryker Increases Quarterly Dividend By 11% To $0.575 Per Share

    Reuters – 8:07 AM ET 02/05/2020

    Stryker Corp (SYK): ER SHARE Source text for Eikon: Further company coverage:

  16. Show article details.

    Stryker declares a $0.575 per share quarterly dividend

    GlobeNewswire – 8:00 AM ET 02/05/2020

    Kalamazoo, Michigan – February 5, 2020 – Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

  17. Show article details.

    BRIEF-Stryker Reports Q4 Adjusted Earnings Per Share $2.49

    Reuters – 5:03 PM ET 01/28/2020

    Stryker Corp (SYK): * STRYKER REPORTS 2019 RESULTS AND 2020 OUTLOOK. * SEES Q1 ADJUSTED EARNINGS PER SHARE $2.05 TO $2.10. * Q4 ADJUSTED EARNINGS PER SHARE $2.49. * Q4 EARNINGS PER SHARE $1.90. * Q4 SALES $4.1 BILLION VERSUS REFINITIV IBES ESTIMATE OF $4.11 BILLION. * Q4 EARNINGS PER SHARE ESTIMATE $2.46 -- REFINITIV IBES DATA.

  18. Show article details.

    Stryker reports 2019 results and 2020 outlook

    GlobeNewswire – 4:05 PM ET 01/28/2020

    Stryker reported operating results for the fourth quarter and full year of 2019 and 2020 outlook: Fourth Quarter Highlights Full Year Highlights "We had an excellent finish to 2019, achieving 8.1% full-year organic sales growth and 13% adjusted EPS gains. This marks our seventh consecutive year of accelerating organic sales growth and is a testament to our talent, culture and durable operating...

  19. Show article details.

    Stryker to host conference call on January 28, 2020

    GlobeNewswire – 1:45 PM ET 01/06/2020

    Kalamazoo, Michigan – January 6, 2020 – Stryker announced that it will host a conference call on Tuesday, January 28, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2019 and provide an operational update.

  20. Show article details.

    Stryker increases dividend 11%, declaring a $0.575 per share quarterly dividend

    GlobeNewswire – 3:00 PM ET 12/04/2019

    Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on January 31, 2020 to shareholders of record at the close of business on December 31, 2019, representing an increase of approximately 11% versus the prior year and the previous quarter.

Page:

Today's and Upcoming Events

  • Apr
    21

    SYK to announce Q1 earnings (Unconfirmed)

Past Events (last 90 days)

  • Mar
    30

    SYK ex-Dividend for $0.58 on 03/30/2020

    • Announce Date: 02/05/2020
    • Record Date: 03/31/2020
    • Pay Date: 04/30/2020
  • Jan
    28

    SYK announced Q4 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.